Clonoseq testing for VISN 1
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- 36C24122A0124
- Awardee
-
Adaptive Biotechnologies Corporation UEI DMW5BNQ331K9
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 6 $167,150 obligated
Award facts
- Combined order value
- $167,150 Current and potential, with all options
- Last date to order 86% complete
- IDV ceiling 20% used
- $828,750.00
- Maximum order
- $165,700.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 1 awarded a Blanket Purchase Agreement to Adaptive Biotechnologies Corporation on July 15, 2022, with a ceiling of $828,750 and ultimate completion date of June 30, 2027.
The BPA provides ClonoSEQ minimal residual disease testing services to VA medical facilities throughout the New England region, supporting clinical diagnostics and treatment monitoring for conditions including multiple myeloma and chronic lymphocytic leukemia. Performance occurs at Boston, West Haven, and Seattle VA locations. Pricing is firm fixed price with no set-aside designation.
Recent BPA calls total over $330,000 to date. A $35,100 call was issued July 15, 2026, for ClonoSEQ testing at Boston and West Haven VA Healthcare System locations, completing July 14, 2027. A $95,000 call was issued July 15, 2025, for the same locations, completing July 14, 2026. A $5,850 call was issued December 6, 2024, for West Haven testing with completion July 14, 2025, and included a $150 deobligation of excess funds. A $11,700 call was issued July 15, 2024, for West Roxbury testing completing July 14, 2025, with a $154,000 deobligation. A $9,750 call was issued July 15, 2023, for Boston and Seattle testing, completing November 25, 2024. An initial $9,750 call was issued July 15, 2022, for Seattle testing completing July 14, 2023, with a $156,000 deobligation closing out the order.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24122A0124?
36C24122A0124 was awarded to Adaptive Biotechnologies Corporation by Veterans Integrated Service Network 1 (Veterans Health Administration) on July 15, 2022.
How much is contract 36C24122A0124 worth?
Orders under 36C24122A0124 have obligated $167,150. 36C24122A0124's own ceiling is $828,750. A single order can be worth up to $165,700.
How many orders have been placed under contract 36C24122A0124?
6 orders have been placed under 36C24122A0124, the latest on July 15, 2026.
Who can order from contract 36C24122A0124?
36C24122A0124 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV